ruthenium and Protein Aggregation, Pathological
ruthenium has been researched along with Protein Aggregation, Pathological in 3 studies
Research
Studies (3)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors
Authors | Studies |
---|---|
Cali, MP; Carlos, RM; Pereira, LMB; Rodrigues, EG; Sellani, TA; Teodoro, MD | 1 |
Peng, YB; Tan, CP; Tao, C; Zhao, P | 1 |
Du, W; He, L; Wang, X; Zhao, C; Zhu, D | 1 |
Other Studies
3 other study(ies) available for ruthenium and Protein Aggregation, Pathological
Article | Year |
---|---|
Comparison of Aβ (1-40, 1-28, 11-22, and 29-40) aggregation processes and inhibition of toxic species generated in early stages of aggregation by a water-soluble ruthenium complex.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Survival; Coordination Complexes; Microscopy, Electron, Transmission; PC12 Cells; Peptide Fragments; Protein Aggregation, Pathological; Rats; Ruthenium; Solubility; Water | 2021 |
Inhibition of Aβ peptide aggregation by ruthenium(II) polypyridyl complexes through copper chelation.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Benzimidazoles; Cell Line, Tumor; Cell Survival; Chelating Agents; Coordination Complexes; Copper; Humans; Mitochondria; Neurons; Oxyquinoline; Protein Aggregates; Protein Aggregation, Pathological; Reactive Oxygen Species; Ruthenium | 2021 |
Inhibitory effects of NAMI-A-like ruthenium complexes on prion neuropeptide fibril formation.
Topics: Coordination Complexes; Copper; Dimethyl Sulfoxide; Humans; Organometallic Compounds; Oxidation-Reduction; Prion Diseases; Prions; Protein Aggregation, Pathological; Ruthenium; Ruthenium Compounds | 2015 |